Sun Pharma launches dry-eye treatment in the US

Sun Pharmaceutical Industries Ltd said one of its wholly-owned subsidiaries has commercialized CEQUA (cyclosporine ophthalmic solution) 0.09% in the U.S. CEQUA, which offers the highest concentration of cyclosporine for ophthalmic use approved by the U.S. Food and Drug Administration (FDA), is indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eye), an inflammatory […]

Sun Pharma licenses two products to China Medical System

Sun Pharmaceutical Industries today announced that it had licensed two of its products — for psoriasis and for dry eye — to China Medical System Holdings Ltd or CMS. CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales, the Indian pharma company said. The financial […]

Sun Pharma issues detailed clarification on corporate governance allegations

Sun Pharmaceutical Industries today announced a list of concrete steps to address investor concerns about certain relationships that it has with a couple of entities and loans allegedly extended to another firm. Sun Pharma stock rose 4.3% on the clarification. ADITYA MEDISALES First, Sun Pharma will move the distribution activities of its India domestic formulations […]

Sun Pharma buys Japanese skin-drug maker Pola Pharma for $1 mln

Sun Pharmaceutical Industries said it agreed to acquire Pola Pharma Inc, a Japanese pharmaceutical company engaged in the research and development, manufacture, sale and distribution of branded and generic products in Japan for $1 million. Pola Pharma had annual revenues of approximately US$ 108 million and net loss of US$ 7 million for the 12 […]

SPARC says cancer formulation study ‘met all endpoints’

Sun Pharma Advanced Research Company Ltd, the research focused unit of Sun Pharma, said a trial of its cancer formulation, Paclitaxel Injection, “met all the endpoints” of a bioequivalence study and the company was looking forward to filing a new drug application. SPARC’s study involved Paclitaxel and Abraxane. If two products are said to be bioequivalent it […]

Sun Pharma gets US FDA okay for eye drug

Sun Pharmaceutical Industries said it has got US Food and Drug Administration  approval for a new eye drug that will be used for lowering intraocular pressure or IOP  in patients with open-angle glaucoma or ocular hypertension. The medicine, latanoprost ophthalmic emulsion, was developed by group company Sun Pharma Advanced Research Co (SPARC), and was licensed by Sun Pharma, […]

Sun Pharma reports strong Apr-Jun numbers, boosted by US, India growth

India’s biggest drug maker Sun Pharmaceutical Industries reported strong numbers for the first quarter of Apr-Jun this year, with rising sales lifting margins and profits. Overall sales rose 16% on year to Rs. 7,139 crores, led by growth in key geographies such as the US, India and emerging markets. This was partly on account of […]

Sun Pharma launches diabetes drug metformin in the US

Sun Pharmaceutical Industries  said it has launched the glucose regulating drug  metformin hydrochloride in the United States. The tablets in two strengths — 500 mg and 1000 mg —  have an addressable market size  of around $443 million, the company said, quoting IQVIA. Metformin hydrochloride is sold in the US by Santarus Inc under the […]

Sun Pharma launches authorized version of Daiichi Sankyo’s cholesterol drug in the US

India-based Sun Pharmaceutical Industries said it has launched an authorized generic version for Daiichi Sankyo’s cholesterol drug Welchol in the US market. The drug, whose compound name is colesevelam hydrochloride, had US sales of approximately US$ 520 million for the 12 months ending March 2018, as per IQVIA, the company said. The launch of the […]

Sun Pharma selects Samsung to manufacture psoriasis drug

Sun Pharma said it has inked a long-term agreement with Samsung BioLogics under which the Korean company will manufacture Tildrakizumab, a potential treatment for plaque psoriasis, for the Indian company. Plaque psoriasis is an autoimmune condition which results in patches of thick, red, scaly skin. The approximate value of the contract will be US$ 55.5 […]

NIV to help Sun Pharma test Zika, Dengue and Chikungunya drugs

Sun Pharma announced a tie-up with National Institute of Virology (NIV) under the Indian Council of Medical Research for testing various compounds for treating rapidly spreading viral infections — Zika, Chikungunya and Dengue. The compounds will include those sourced from plants, animals and chemical entities developed by Sun Pharma. NIV will do the testing against […]

Sun Pharma to get dengue vaccine technology from ICGEB

Pharma major Sun Pharma said it tied up with research organization International Centre for Genetic Engineering and Biotechnology to develop vaccines for dengue. The vaccine is targeted against all the four serotypes of Dengue virus that cause disease in humans and is being developed to commercialize in Indian and international markets. A serotype is a […]